COVID-19 | Treatments

 Healthcare providers should advise patients on strategies to ensure medication adherence and continuity. Plans should be in place and ample supplies should be available to address any potential shortages or needs for rescue therapies.

If feasible, providers might consider writing 90-day rather than 30-day supplies of medications. 


COVID-19 Vaccine Information


Monitoring Drug Shortages


Managing Medications



Changes in Prescription Guidance

DEA: Temporary flexibility to prescribe buprenorphine for the treatment of opioid use disorder based on an evaluation via telephone